• Daniel Aharonoff: Earnings Engage: The Business Pulse

  • By: Daniel Aharonoff
  • Podcast

Daniel Aharonoff: Earnings Engage: The Business Pulse

By: Daniel Aharonoff
Listen for free

  • Summary

  • Get your weekly dose of corporate financial health checks with Daniel Aharonoff on 'Earnings Engage: The Business Pulse.' We dissect quarterly earnings reports, explore market implications, and provide you with a concise yet comprehensive look at the financial performance of various businesses. Tune in to stay updated and informed! Visit https://aharonofftechtales.com for more | Produced by Daniel Aharonoff & Mogul Media AI
    © 2025 Daniel Aharonoff
    Show More Show Less
Economics
Show More Show Less
Episodes
  • Micron Shares Drop After Weak Q2 Guidance

    Micron Shares Drop After Weak Q2 Guidance
    Jan 14 2025
    Read More: https://www.cnbc.com/2024/12/18/micron-shares-plunge-on-weak-second-quarter-guidance.html

    Micron Technology recently faced a significant setback as its shares took a nosedive in extended trading. The chipmaker's announcement of weaker-than-expected guidance for the second quarter has left investors rattled, raising concerns about the company's future performance. As the tech industry continues to evolve rapidly, this unexpected news highlights the volatility in the semiconductor market and the challenges that companies like Micron are currently navigating. The reaction from investors reflects a cautious approach as they reassess their positions and consider the implications of this guidance on their portfolios.
    Show More Show Less
    Less than 1 minute
  • Pfizer Projects 2025 Profit Aligned with Expectations

    Pfizer Projects 2025 Profit Aligned with Expectations
    Jan 13 2025
    Read More: https://www.cnbc.com/2024/12/17/pfizer-forecasts-2025-profit-in-line-with-expectations.html

    Pfizer has recently shared an optimistic forecast for its profits in 2025, aligning closely with Wall Street expectations, which is a welcome sign for investors after a challenging year. The pharmaceutical giant's projection not only reflects confidence in its ongoing recovery but also hints at potential growth driven by new innovations and strategic initiatives. This positive outlook may help restore investor trust and stabilize the company's market position as it navigates through the complexities of the healthcare landscape. As Pfizer focuses on turning things around, stakeholders are keenly watching for signs that the company can regain its footing and thrive in the competitive pharmaceutical industry.
    Show More Show Less
    Less than 1 minute
  • Broadcom Shares Surge 17% Amid Mixed Results

    Broadcom Shares Surge 17% Amid Mixed Results
    Jan 10 2025
    Read More: https://www.cnbc.com/2024/12/12/ai-chipmaker-broadcom-shares-soar-14percent-despite-mixed-quarterly-results-heres-why-.html

    Broadcom, a leading A I chipmaker, has experienced a remarkable surge in its stock price, climbing 17% despite reporting mixed quarterly results. This unexpected rise is largely fueled by a series of optimistic updates from the A I sector, showcasing the company's resilience and potential for growth. Analysts are responding positively, adjusting their price targets upward, which reflects a growing confidence in Broadcom's ability to navigate the evolving tech landscape. As the A I market continues to expand, investors are keenly watching Broadcom's next moves, eager to see how the company capitalizes on its momentum.
    Show More Show Less
    Less than 1 minute

What listeners say about Daniel Aharonoff: Earnings Engage: The Business Pulse

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available